Save time and get answers to complex questions with AI chat
Drugpatentwatch trametinib?Zemdri nce gain exclusivity 2028 patent 2031?Complera manufacturer?Guselkumab patent expiration?Combivent generic equivalent?
See the DrugPatentWatch profile for Ofatumumab
Ofatumumab (a monoclonal antibody developed by Novartis) is marketed under the brand name Arzerra for certain blood cancers in which it’s indicated. [1]
Typically, ofatumumab is recognized by the brand name Arzerra. If you see a different name in a country or setting, it is usually because of local marketing or distributor branding rather than a different drug substance. [1]
You can cross-check brand naming and related drug information on DrugPatentWatch.com here: [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Ofatumumab :